| |
| |
|
| Insider
Information: |
Slawin Kevin M. |
| Relationship: |
Director |
| City: |
Houston |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
84,206 |
|
|
Indirect Shares
|
693,049 |
|
|
| Direct
Value |
$6,294 |
|
|
|
Indirect Value
|
$51,805 |
|
|
| Total
Shares |
777,255 |
|
|
| Total
Value |
$58,100 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2017-02-07 |
84,206 |
2017-02-07 |
693,049 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2017-02-07 |
4 |
AS |
$12.54 |
$376,215 |
I/I |
(30,000) |
294,982 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-12-15 |
4 |
AS |
$15.45 |
$463,539 |
I/I |
(30,000) |
324,982 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-23 |
4 |
AS |
$20.11 |
$240,530 |
I/I |
(11,958) |
354,982 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-23 |
4 |
AS |
$20.12 |
$226,549 |
D/D |
(11,258) |
84,206 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-21 |
4 |
AS |
$20.04 |
$2,004 |
I/I |
(100) |
366,940 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-21 |
4 |
AS |
$20.04 |
$2,004 |
D/D |
(100) |
95,464 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-20 |
4 |
AS |
$20.00 |
$6,000 |
D/D |
(300) |
95,564 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-20 |
4 |
AS |
$20.00 |
$2,000 |
I/I |
(100) |
367,040 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-19 |
4 |
AS |
$20.01 |
$24,129 |
I/I |
(1,206) |
367,140 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-19 |
4 |
AS |
$20.02 |
$28,024 |
D/D |
(1,400) |
95,864 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-16 |
4 |
AS |
$20.00 |
$12,720 |
I/I |
(636) |
368,346 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-09-16 |
4 |
AS |
$20.00 |
$18,840 |
D/D |
(942) |
97,264 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-08-15 |
4 |
AS |
$19.27 |
$598,931 |
I/I |
(31,000) |
368,982 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-08-15 |
4 |
AS |
$19.27 |
$695,012 |
D/D |
(36,000) |
98,206 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-07-27 |
4 |
AS |
$15.00 |
$225,000 |
I/I |
(15,000) |
399,982 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-07-18 |
4 |
AS |
$13.99 |
$38,044 |
D/D |
(2,719) |
134,206 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-07-15 |
4 |
AS |
$13.72 |
$305,677 |
D/D |
(22,281) |
136,925 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-04-22 |
4 |
AS |
$11.42 |
$342,788 |
I/I |
(30,000) |
414,982 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2016-04-22 |
4 |
AS |
$11.43 |
$285,710 |
D/D |
(25,000) |
159,206 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2015-11-16 |
4 |
AS |
$20.65 |
$371,632 |
I/I |
(18,000) |
398,066 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2015-11-16 |
4 |
AS |
$20.65 |
$123,877 |
D/D |
(6,000) |
184,206 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2015-07-15 |
4 |
AS |
$20.00 |
$30,000 |
D/D |
(1,500) |
163,008 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• • – |
2015-07-15 |
4 |
AS |
$20.00 |
$90,000 |
I/I |
(4,500) |
402,066 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CMO and CTO |
• • – |
2014-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
37,743 |
164,507 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CMO and CTO |
• • – |
2014-12-23 |
4 |
A |
$0.00 |
$0 |
I/I |
2,537 |
115,198 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
